$SIGA
SIGA Technologies Inc

2014 Q1 Form 10-K Financial Statement

#000101008614000006 Filed on March 10, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2012 Q4 2012 Q3
Revenue $500.0K $2.500M $2.300M
YoY Change -61.54% -50.0% -36.11%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.039M $2.583M $3.139M
YoY Change 1.84% -59.4% -20.91%
% of Gross Profit
Research & Development $2.813M $4.396M $4.170M
YoY Change -22.83% -24.15% -19.34%
% of Gross Profit
Depreciation & Amortization $91.11K $110.0K $100.0K
YoY Change -7.16% 10.0% -16.67%
% of Gross Profit
Operating Expenses $6.188M $6.979M $7.686M
YoY Change -13.27% -42.6% -20.12%
Operating Profit -$5.638M -$5.259M -$5.396M
YoY Change -2.91% -32.31% -10.71%
Interest Expense $140.8K $900.0K $0.00
YoY Change -62.3% -94.34% -100.0%
% of Operating Profit
Other Income/Expense, Net $5.00 $0.00 $94.00
YoY Change -95.15% -71.43%
Pretax Income -$5.623M -$4.400M -$5.529M
YoY Change -21.4% -154.32% 319.9%
Income Tax -$2.241M -$1.800M -$2.470M
% Of Pretax Income
Net Earnings -$3.382M -$2.618M -$3.059M
YoY Change -30.64% -54.52% -1556.67%
Net Earnings / Revenue -676.4% -104.72% -133.0%
Basic Earnings Per Share -$0.06 -$0.06
Diluted Earnings Per Share -$63.79K -$0.06 -$0.06
COMMON SHARES
Basic Shares Outstanding 53.26M shares 51.64M shares 51.64M shares
Diluted Shares Outstanding 51.64M shares

Balance Sheet

Concept 2014 Q1 2012 Q4 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.1M $32.00M $22.70M
YoY Change 333.6% -35.09% 83.06%
Cash & Equivalents $107.1M $32.02M $22.67M
Short-Term Investments
Other Short-Term Assets $8.600M $34.30M $1.400M
YoY Change -75.07% 3018.18% 250.0%
Inventory $17.08M $17.64M $17.36M
Prepaid Expenses $675.2K
Receivables $610.4K $970.3K $1.095M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $133.3M $84.95M $42.54M
YoY Change 28.79% 60.34% 193.38%
LONG-TERM ASSETS
Property, Plant & Equipment $1.085M $987.9K $774.7K
YoY Change -6.36% 20.62% -3.16%
Goodwill $898.3K $898.3K $898.3K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.025M $2.182M $1.626M
YoY Change -4.72% 664.59% -95.3%
Total Long-Term Assets $81.45M $20.89M $49.51M
YoY Change 223.28% -44.15% 36.4%
TOTAL ASSETS
Total Short-Term Assets $133.3M $84.95M $42.54M
Total Long-Term Assets $81.45M $20.89M $49.51M
Total Assets $214.8M $105.8M $92.05M
YoY Change 66.86% 17.1% 81.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.344M $10.19M $10.61M
YoY Change -49.43% 347.26% 382.43%
Accrued Expenses $4.661M $4.284M $5.183M
YoY Change 2.0% -7.76% 245.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.974M $954.7K
YoY Change 35.74%
Total Short-Term Liabilities $11.14M $15.76M $15.80M
YoY Change -26.51% 127.69% 326.94%
LONG-TERM LIABILITIES
Long-Term Debt $1.494M $3.955M $0.00
YoY Change -56.91%
Other Long-Term Liabilities $188.2M $57.90M $44.50M
YoY Change 122.46% 35.92% 3945.45%
Total Long-Term Liabilities $1.494M $3.955M $44.50M
YoY Change -56.91% 3945.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.14M $15.76M $15.80M
Total Long-Term Liabilities $1.494M $3.955M $44.50M
Total Liabilities $200.9M $77.59M $60.31M
YoY Change 94.57% 59.35% 1156.51%
SHAREHOLDERS EQUITY
Retained Earnings -$159.9M -$139.4M -$120.2M
YoY Change 10.87% 28.0%
Common Stock $173.8M $167.6M $151.9M
YoY Change 2.43% 11.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.94M $28.24M $31.74M
YoY Change
Total Liabilities & Shareholders Equity $214.8M $105.8M $92.05M
YoY Change 66.86% 17.1% 81.2%

Cashflow Statement

Concept 2014 Q1 2012 Q4 2012 Q3
OPERATING ACTIVITIES
Net Income -$3.382M -$2.618M -$3.059M
YoY Change -30.64% -54.52% -1556.67%
Depreciation, Depletion And Amortization $91.11K $110.0K $100.0K
YoY Change -7.16% 10.0% -16.67%
Cash From Operating Activities $16.59M $4.760M -$12.25M
YoY Change -305.01% -87.21% 322.41%
INVESTING ACTIVITIES
Capital Expenditures $14.18K -$330.0K -$10.00K
YoY Change -94.72% 153.85% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$14.18K -$330.0K -$20.00K
YoY Change -94.72% 153.85% -100.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $500.0K
YoY Change
Cash From Financing Activities -$821.3K 4.910M 10.00K
YoY Change -179.33% -2064.0% -96.97%
NET CHANGE
Cash From Operating Activities $16.59M 4.760M -12.25M
Cash From Investing Activities -$14.18K -330.0K -20.00K
Cash From Financing Activities -$821.3K 4.910M 10.00K
Net Change In Cash $15.76M 9.340M -12.26M
YoY Change -315.06% -74.65% -265.45%
FREE CASH FLOW
Cash From Operating Activities $16.59M $4.760M -$12.25M
Capital Expenditures $14.18K -$330.0K -$10.00K
Free Cash Flow $16.58M $5.090M -$12.24M
YoY Change -298.25% -86.38% 323.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
970288 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5064380 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10189917 USD
CY2013Q4 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
0 USD
CY2012Q4 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
3771219 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
982023 USD
CY2012Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
250000 USD
CY2013Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
0 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4842393 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4283849 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
579609 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
794275 USD
CY2012Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
328463 USD
CY2013Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
252410 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4938372 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5401509 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
167588375 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
173498028 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12463772 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2172597 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1779515 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1600000 USD
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12500000 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1800000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2300000 USD
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
504668 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2012Q4 us-gaap Assets
Assets
105836130 USD
CY2013Q4 us-gaap Assets
Assets
193824234 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
123941842 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
84946176 USD
CY2013Q4 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
110000000 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91309754 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32017490 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49256930 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6332053 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17239440 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
59292264 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
42924877 USD
CY2006Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
4.99
CY2006Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53108844 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51642520 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51642520 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53108844 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
5164 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
5310 USD
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29095512 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17177333 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14059539 USD
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has cash in bank accounts that exceed the Federal Deposit Insurance Corporation insured limits. The Company has not experienced any losses on its cash accounts and no allowance has been provided for potential credit losses because management believes that any such losses would be minimal, if any. </font></div></div>
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1608033 USD
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2011 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3649 USD
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20332 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1981488 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
373455 USD
CY2011 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
20332 USD
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3649 USD
CY2012 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0525
CY2013Q4 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
167000 USD
CY2012Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
90000 USD
CY2013Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
41226 USD
CY2013Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
4000000 USD
CY2012Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
5000000 USD
CY2012Q4 us-gaap Deferred Costs
DeferredCosts
2841534 USD
CY2013Q4 us-gaap Deferred Costs
DeferredCosts
22583202 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
-604973 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
-709184 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
49273789 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
53324532 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
43724605 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
61490236 USD
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-10072499 USD
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-7557163 USD
CY2011 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-35493317 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9599927 USD
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-36051978 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7847802 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
57052020 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
162222189 USD
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
472572 USD
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-290639 USD
CY2011 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-558661 USD
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
48685086 USD
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
4403266 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
65933165 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
44945556 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
10383908 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
33515327 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
42940624 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
10209278 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7750690 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36764901 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
1200000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
212483 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
554777 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
1608033 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2166125 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1768990 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
892129 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
942529 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4442929 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4328233 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
-2278397 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
-2950555 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
203682 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
224908 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
-1572281 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
-1342555 USD
CY2012Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2013Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24795772 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6932067 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
463137 USD
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
568288 USD
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
419358 USD
CY2012 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2011 us-gaap Dilutive Securities
DilutiveSecurities
-24436309 USD
CY2013 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.359
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.307
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
5.195
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
3.876
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.006
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.005
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.004
CY2011 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.248
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.008
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.014
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.014
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.003
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.029
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
23668 USD
CY2011 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
488168 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
345287 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-21903692 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-36031646 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7844153 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7618439 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2659597 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4566993 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7550989 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-365041 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2104404 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3759484 USD
CY2011 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
250072 USD
CY2012 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
2591462 USD
CY2013 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
19741668 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
105170169 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
16050910 USD
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
41001110 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17641922 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2873427 USD
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-147621 USD
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4697 USD
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
548419 USD
CY2012 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
18717 USD
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
281302 USD
CY2011 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
147586 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-188101 USD
CY2012 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
444251 USD
CY2011 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-12119 USD
CY2011 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3132159 shares
CY2012 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2011 us-gaap Interest Expense
InterestExpense
0 USD
CY2012 us-gaap Interest Expense
InterestExpense
172993 USD
CY2013 us-gaap Interest Expense
InterestExpense
1207332 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14363151 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
20515349 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
17641922 USD
CY2013Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
6152198 USD
CY2012Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
17641922 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
272729 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2817123 USD
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3166622 USD
CY2012Q4 us-gaap Liabilities
Liabilities
77593128 USD
CY2013Q4 us-gaap Liabilities
Liabilities
176848766 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
193824234 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
105836130 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15762297 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12189024 USD
CY2012Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
7000000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
3958774 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1968826 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
954738 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2000000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2000000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3955262 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1989948 USD
CY2012Q4 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.0985
CY2013Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
2635270 USD
CY2012Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
2491981 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2473428 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2305410 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1713103 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2592581 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4919577 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1936191 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-857341 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14758260 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25574036 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
58436502 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20222826 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-14059539 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
29099579 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-17177333 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-4338000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-4876000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-3061000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-4902000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-2618000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-3767000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-3059000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-4616000 USD
CY2012 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-14059539 USD
CY2013 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-17177333 USD
CY2011 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
4663270 USD
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13061 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1497 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
522 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
31506572 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
29035481 USD
CY2011 us-gaap Operating Expenses
OperatingExpenses
44107229 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-22535737 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-31381437 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-23516181 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6513000 USD
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4067 USD
CY2012Q4 us-gaap Other Liabilities
OtherLiabilities
166303 USD
CY2013Q4 us-gaap Other Liabilities
OtherLiabilities
447605 USD
CY2012 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2011 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2013 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-48774 USD
CY2013 us-gaap Payments For Restructuring
PaymentsForRestructuring
206385 USD
CY2012 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
386000 USD
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
178952 USD
CY2011 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1353656 USD
CY2012 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5633000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5564000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5807000 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5259000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5396000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5549000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6332000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
8532168 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1602840 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
734360 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1661844 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1642176 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1622508 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1268440 USD
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
23500000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
633796 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1160438 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2078159 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2181720 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
857341 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
237023 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
588235 USD
CY2012 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2011 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
25004717 USD
CY2013 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
801149 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
750808 USD
CY2011 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7000000 USD
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4910000 USD
CY2011 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
9531911 USD
CY2013 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
751370 USD
CY2012 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2011 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
40000000 USD
CY2013 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
247833 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2868387 USD
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3946237 USD
CY2011 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
25000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6783582 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5926241 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
987869 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1382073 USD
CY2012 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2013Q1 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8000000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18213036 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13856500 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18367348 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2819000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3645000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4261000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3131000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5183000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4465000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4170000 USD
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4396000 USD
CY2013 us-gaap Restructuring Charges
RestructuringCharges
512944 USD
CY2011 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2013Q4 us-gaap Restructuring Charges
RestructuringCharges
513000 USD
CY2013Q3 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2013 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
188329 USD
CY2013Q4 us-gaap Restructuring Reserve
RestructuringReserve
118230 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-139350537 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-156527870 USD
CY2010Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4500000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2013960 shares
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13244819 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11410131 USD
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23931713 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3031000 USD
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3782000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3166000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3266000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3139000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2214000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3475000 USD
CY2012Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2583000 USD
CY2013 us-gaap Severance Costs1
SeveranceCosts1
324615 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
12463772 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
2263506 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
1779515 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.09
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
69455 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
27000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.01
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.34
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.77
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
849950 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2902708 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2353630 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
844331 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2343414 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.91
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
663128 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y11M28D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M3D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y1M7D
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
506623 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
28243002 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
16975468 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
40770859 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-12912917 USD
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51639622 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54061650 shares
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and related disclosures are prepared in conformity with accounting principles generally accepted in the United States of America. Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the period reported. The most significant estimates include the variables used in the calculation of fair value of stock-based awards including options and warrants granted or issued by the Company; reported amounts of revenue and expenses; impairment of goodwill; and the realization of deferred tax assets. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary. Actual results could differ from these estimates.</font></div></div>
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52368842 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52368842 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51639622 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50929491 shares
CY2013 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
73756 USD
CY2011 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-24436309 USD
CY2012 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-804516 USD
CY2013Q4 siga Common Stock Warrants Current Fair Value Disclosure
CommonStockWarrantsCurrentFairValueDisclosure
313425 USD
CY2012Q4 siga Common Stock Warrants Current Fair Value Disclosure
CommonStockWarrantsCurrentFairValueDisclosure
333793 USD
CY2012Q4 siga Common Stock Warrants Noncurrent Fair Value Disclosure
CommonStockWarrantsNoncurrentFairValueDisclosure
657246 USD
CY2013Q4 siga Common Stock Warrants Noncurrent Fair Value Disclosure
CommonStockWarrantsNoncurrentFairValueDisclosure
0 USD
CY2012Q4 siga Computer Equipment
ComputerEquipment
458421 USD
CY2013Q4 siga Computer Equipment
ComputerEquipment
655364 USD
CY2013Q4 siga Contractreceivablecollectedresearchanddevelopemntservices
Contractreceivablecollectedresearchanddevelopemntservices
5400000 USD
CY2012 siga Debt Instrument Descriptionof Variable Rate Basis1
DebtInstrumentDescriptionofVariableRateBasis1
0.015
CY2013 siga Deferred Tax Assts Operating Loss Carryforwards Subjectto Limitations
DeferredTaxAsstsOperatingLossCarryforwardsSubjecttoLimitations
3100000 USD
CY2013Q4 siga Deferred Tax Liabilities Capitalized Contract Costs
DeferredTaxLiabilitiesCapitalizedContractCosts
7940796 USD
CY2012Q4 siga Deferred Tax Liabilities Capitalized Contract Costs
DeferredTaxLiabilitiesCapitalizedContractCosts
1017269 USD
CY2011 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
1.234
CY2013 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
-0.001
CY2012 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
0.013
CY2012 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
-804516 USD
CY2011 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
-24436309 USD
CY2012 siga Loan Term
LoanTerm
P3Y
CY2013Q4 siga Receivables Percentage
ReceivablesPercentage
1
CY2013 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
73756 USD
CY2012 siga Inventory Write Downs
InventoryWriteDowns
500000 USD
CY2012Q4 siga Line Of Credit Facility Borrowing Base Percentage
LineOfCreditFacilityBorrowingBasePercentage
0.85
CY2013 siga Number Of Active Contracts
NumberOfActiveContracts
1 contract
CY2013 siga Number Of Active Grants
NumberOfActiveGrants
2 grant
CY2011 siga Patent Preparation Fees
PatentPreparationFees
1808168 USD
CY2012 siga Patent Preparation Fees
PatentPreparationFees
1883405 USD
CY2013 siga Patent Preparation Fees
PatentPreparationFees
1421218 USD
CY2013Q4 siga Patent Preparation Fees
PatentPreparationFees
333000 USD
CY2013Q1 siga Patent Preparation Fees
PatentPreparationFees
458000 USD
CY2013Q2 siga Patent Preparation Fees
PatentPreparationFees
301000 USD
CY2013Q3 siga Patent Preparation Fees
PatentPreparationFees
329000 USD
CY2012Q4 siga Patent Preparation Fees
PatentPreparationFees
794000 USD
CY2012Q3 siga Patent Preparation Fees
PatentPreparationFees
377000 USD
CY2012Q2 siga Patent Preparation Fees
PatentPreparationFees
376000 USD
CY2012Q1 siga Patent Preparation Fees
PatentPreparationFees
336000 USD
CY2011 siga Payment Of Collateral For Commercial Surety Bond
PaymentOfCollateralForCommercialSuretyBond
0 USD
CY2013 siga Payment Of Collateral For Commercial Surety Bond
PaymentOfCollateralForCommercialSuretyBond
0 USD
CY2012 siga Payment Of Collateral For Commercial Surety Bond
PaymentOfCollateralForCommercialSuretyBond
1347956 USD
CY2013Q4 siga Potential Future Aggregate Research And Development Expenses
PotentialFutureAggregateResearchAndDevelopmentExpenses
13900000 USD
CY2012 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
9577 USD
CY2011 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
3946237 USD
CY2013 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
2868387 USD
CY2012Q4 siga Receivables Percentage
ReceivablesPercentage
1
CY2012 siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
0 USD
CY2011 siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
9531911 USD
CY2013 siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
751370 USD
CY2012 siga Rent Expense Facilities Lease
RentExpenseFacilitiesLease
1000000 USD
CY2011 siga Rent Expense Facilities Lease
RentExpenseFacilitiesLease
827000 USD
CY2013 siga Rent Expense Facilities Lease
RentExpenseFacilitiesLease
1400000 USD
CY2012 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
8970835 USD
CY2011 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
12725792 USD
CY2013 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
5519300 USD
CY2013Q4 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
934000 USD
CY2013Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
965000 USD
CY2013Q1 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1328000 USD
CY2013Q3 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
2292000 USD
CY2012Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
2701000 USD
CY2012Q3 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
2290000 USD
CY2012Q4 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
2514000 USD
CY2012Q1 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1466000 USD
CY2013 siga Researchand Development Revenue Longterm Contract
ResearchandDevelopmentRevenueLongtermContract
1200000 USD
CY2013 siga Restructuringand Related Cost Expected Expense Reduction
RestructuringandRelatedCostExpectedExpenseReduction
6000000 USD
CY2012Q4 siga Share Based Compensation Arrangement By Share Based Payment Award Options Performance Based Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformanceBasedNumber
500000 shares
CY2013Q4 siga Share Based Compensation Arrangement By Share Based Payment Award Options Performance Based Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformanceBasedNumber
500000 shares
CY2013Q4 siga Term Extension
TermExtension
P5Y
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001010086
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53262322 shares
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q2 dei Entity Public Float
EntityPublicFloat
148806051 USD
CY2013 dei Entity Registrant Name
EntityRegistrantName
SIGA TECHNOLOGIES INC
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Trading Symbol
TradingSymbol
SIGA

Files In Submission

Name View Source Status
0001010086-14-000006-index-headers.html Edgar Link pending
0001010086-14-000006-index.html Edgar Link pending
0001010086-14-000006.txt Edgar Link pending
0001010086-14-000006-xbrl.zip Edgar Link pending
exhibit101-01cmodification.htm Edgar Link pending
exhibit102-01cmodification.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
item5graph2013.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20131231.xml Edgar Link completed
siga-20131231.xsd Edgar Link pending
siga-20131231x10k.htm Edgar Link pending
siga-20131231_cal.xml Edgar Link unprocessable
siga-20131231_def.xml Edgar Link unprocessable
siga-20131231_lab.xml Edgar Link unprocessable
siga-20131231_pre.xml Edgar Link unprocessable
siga-exhibit2312013ye.htm Edgar Link pending
siga-exhibit3112013ye.htm Edgar Link pending
siga-exhibit3122013ye.htm Edgar Link pending
siga-exhibit3212013ye.htm Edgar Link pending
siga-exhibit3222013ye.htm Edgar Link pending